Bora Pharmaceuticals

6472.TW

22.90 USD

0.13

+0.57%

Overview

Last close

22.90 usd

Market cap

2.32B usd

52 week high

29.35 usd

52 week low

19.39 usd

Target price

29.9 usd

Valuation

P/E

20.0701

Forward P/E

N/A

Price/Sales

5.4003

Price/Book Value

6.4117

Enterprise Value

2.69B usd

EV/Revenue

5.2696

EV/EBITDA

14.2636

Key financials

Revenue TTM

433.20M usd

Gross Profit TTM

N/A usd

EBITDA TTM

141.40M usd

Earnings per Share

1.13 usd

Dividend

N/A usd

Total assets

43.35B usd

Net debt

13.12B usd

About

Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services, including clinical and commercial manufacturing, pharmaceutical development, packaging and serialization, analytical and microbiology testing, and regulatory affairs services. In addition, it provides food and vitamin supplements, and skincare products; and biotechnical services. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei City, Taiwan.